Tamburrini, Enrica
 Distribuzione geografica
Continente #
EU - Europa 3.442
NA - Nord America 3.412
AS - Asia 1.554
SA - Sud America 359
AF - Africa 72
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 8
Totale 8.875
Nazione #
US - Stati Uniti d'America 3.320
DE - Germania 739
IT - Italia 640
SE - Svezia 605
SG - Singapore 605
CN - Cina 458
FR - Francia 388
BR - Brasile 329
UA - Ucraina 261
IE - Irlanda 198
GB - Regno Unito 162
FI - Finlandia 129
ID - Indonesia 113
IN - India 97
RU - Federazione Russa 68
PL - Polonia 67
CA - Canada 66
TR - Turchia 46
AT - Austria 36
NL - Olanda 33
BE - Belgio 30
HK - Hong Kong 29
AU - Australia 25
IR - Iran 24
KR - Corea 20
CI - Costa d'Avorio 19
SA - Arabia Saudita 19
MX - Messico 17
VN - Vietnam 17
PK - Pakistan 16
ES - Italia 15
PH - Filippine 13
CH - Svizzera 12
MA - Marocco 12
RO - Romania 12
BD - Bangladesh 11
MY - Malesia 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 10
EG - Egitto 9
JP - Giappone 9
PE - Perù 9
TN - Tunisia 9
EU - Europa 7
IL - Israele 7
IQ - Iraq 7
UZ - Uzbekistan 7
CO - Colombia 6
GR - Grecia 6
JO - Giordania 6
NP - Nepal 6
LT - Lituania 5
AR - Argentina 4
BG - Bulgaria 4
KZ - Kazakistan 4
PT - Portogallo 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
LV - Lettonia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SD - Sudan 3
TW - Taiwan 3
CL - Cile 2
CM - Camerun 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
GL - Groenlandia 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
PR - Porto Rico 1
RS - Serbia 1
Totale 8.870
Città #
Chandler 740
Singapore 341
Ashburn 280
Dublin 194
Jacksonville 159
San Mateo 149
New York 145
Rome 123
Milan 122
Jakarta 112
Ann Arbor 88
Nanjing 84
Wilmington 84
Dearborn 71
Helsinki 67
The Dalles 57
Boston 56
Kraków 53
Moscow 51
Chicago 50
Woodbridge 50
Princeton 49
Marseille 48
Lawrence 43
Los Angeles 42
Cattolica 40
Frankfurt am Main 36
Munich 36
Beijing 34
Boardman 34
Izmir 34
Houston 33
Bremen 31
Hefei 30
Lancaster 30
Seattle 30
Redwood City 29
Nuremberg 28
Nürnberg 27
Brussels 26
Nanchang 24
São Paulo 23
Hong Kong 22
Norwalk 22
Ottawa 22
Vienna 22
Augusta 20
Fairfield 20
London 20
Düsseldorf 19
Trieste 19
Abidjan 18
Amsterdam 18
Lauterbourg 18
Mountain View 18
Seoul 18
Pune 16
Toronto 16
University Park 16
Guangzhou 15
Hebei 15
Washington 15
Jiaxing 14
Shenyang 13
Tianjin 13
Fremont 12
Hangzhou 12
North Bergen 12
Rio de Janeiro 12
Andover 11
Dammam 11
Portsmouth 11
Zhengzhou 11
Zurich 11
Kish 10
Leawood 10
Oggiono 10
Paris 10
Roubaix 10
Verona 10
Changsha 9
Cuauhtémoc 9
Falls Church 9
Jinan 9
Kunming 9
San Francisco 9
San Giovanni Bianco 9
Bexley 8
Hyderabad 8
Phoenix 8
Richmond 8
Sydney 8
Turin 8
Al Qatif 7
Brasília 7
Brooklyn 7
Florence 7
Madrid 7
Mexico City 7
San Diego 7
Totale 4.515
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 455
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 235
Excretion of SARS-CoV-2 in human breast milk 154
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 149
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 145
Assessment of neurological manifestations in hospitalized patients with COVID-19 137
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 136
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 132
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 131
Migranti cinesi in gravidanza: stato sierologico relativo alle principali malattie infettive ed accesso ai servizi sanitari. L’esperienza nelle comunità di Roma e Prato 124
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 122
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 119
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 119
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 116
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 116
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 115
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 114
Cognitive reserve and neuropsychological functioning in older HIV-infected people 114
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 113
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 112
Oral lesions in HIV and HCV co-infected individuals in HAART era 110
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 110
Rubella susceptibility profile in pregnant women with HIV 109
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 106
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 105
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 102
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 96
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 95
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 95
Sarilumab use in severe SARS-CoV-2 pneumonia 95
Residual respiratory impairment after COVID-19 pneumonia 95
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 90
Oral lesions in HIV and HCV co-infected individuals in HAART era 89
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 89
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 88
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 88
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 87
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 86
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 86
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. 85
Dental care and HIV-infected individuals: are they equally treated? 85
Glucose plasma levels and pregnancy outcomes in women with HIV 80
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 80
Rubella susceptibility profile in pregnant women with HIV 79
Enhancement of vaccination attitude and flu vaccination coverage among pregnant women attending birthing preparation course 78
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 77
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 77
Residual respiratory impairment after COVID-19 pneumonia 76
Pregnancy outcomes in women with advanced HIV infection in Italy 76
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens 76
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 75
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 75
Antiretroviral treatment in pregnancy: a six-years perspective on recent trands in prescription patterns, viral load suppression, and pregnancy outcomes. 74
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 73
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 73
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001-2011 72
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 72
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 72
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 71
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: A multicentre case series 71
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine 70
Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women 69
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 68
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 66
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 65
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 65
Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy 64
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 64
Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero 63
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 63
HCV–HIV coinfected pregnant women: data from a multicentre study in Italy 62
Risk factors for bloodstream infections in gynecological cancer 61
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 61
Glucose plasma levels and pregnancy outcomes in women with HIV 60
People Living with HIV in the COVID-19 Era: A Case Report 60
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 59
In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers 59
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 58
Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2 57
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 57
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 56
Pregnancy outcomes in women with advanced HIV infection in Italy 56
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 56
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 56
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report 55
Pregnancy outcomes in HIV-infected women of advanced maternal age 55
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study 54
HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy 53
Body mass index and weight gain in pregnant women with HIV: a national study in Italy 51
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 51
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1 51
Off-label use of tocilizumab in patients with SARS-CoV-2 infection 48
People Living with HIV in the COVID-19 Era: A Case Report 47
Is smallpox vaccination protective against human monkeypox? 45
Women Facing HIV. Key Question on Women with HIV Infection: Italian Consensus Workshop 45
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 44
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 44
COVID-19 diagnosis does not rule out other concomitant diseases 43
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 43
Declining HCV seroprevalence in pregnant women with HIV 42
Totale 8.622
Categoria #
all - tutte 44.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 0 0 0 0 0 60
2020/2021666 25 64 10 64 91 37 86 16 95 44 113 21
2021/2022950 106 63 22 67 35 24 37 160 37 67 135 197
2022/20232.437 252 284 214 407 236 311 107 178 255 80 87 26
2023/20241.225 46 297 40 77 63 206 79 36 37 63 121 160
2024/20252.021 39 59 227 76 197 80 111 114 392 231 458 37
Totale 9.010